• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Adrian F. Hernandez: Mapping Human Health Through Project Baseline

Video

The purpose of Project Baseline is to map human health so we can convert from a reactive healthcare system to a proactive healthcare system, explained Adrian F. Hernandez, MD, MHS, vice dean, clinical research, Duke University School of Medicine

This page contains sponsored advertising.

In some ways, the United States is progressive in its use of real-world evidence, but there are still areas where other countries do a better job of incorporating such evidence into the health system, explained Adrian F. Hernandez, MD, MHS, vice dean, clinical research, Duke University School of Medicine.

Transcript

What is Project Baseline? What is the purpose and how along into the study are you?

Project Baseline is a study that’s partnered between Duke, Stanford, and Verily, which is a subsidiary of Alphabet, and the main goal is to map human health. Just like the roads have been mapped in the past in terms of understanding how to get from point a from point b, to the same thing in terms of what do we understand about health today and understand transitions from other health states tomorrow or a year from now and then incorporating a variety of signals that would help us map out what someone’s health trajectory is.

An example is having a foundation of genomics or a foundation of what’s in their environment or a foundation of what their microbiome is, and then over time seeing how that changes, and picking up new signals from their daily activity to how they’re feeling to how they’re sleeping, and then incorporating all of that to see if we can have better signals and converting from a reactive healthcare system to a proactive system so that we can actually do something to so-called prevent the car crash in health like for how we do with Google Maps.

Related Videos
Kimberly Westrich, MA, chief strategy officer at the National Pharmaceutical Council
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center
Jawad Haider Butt, MD, PhD
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Barry Byrne, MD, PhD, Powell Gene Therapy Center at the University of Florida
JC Scott, CEO and president, PCMA
Caspian Oliai, MD, MS, a medical oncologist and hematologist and medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Adam Colburn, JD, vice president for congressional affairs, AMCP
Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.